Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Adding tumor-bed biopsy to trimodality imaging after neoadjuvant chemotherapy did not reliably predict pathological complete ...

Patients with advanced non-small cell lung cancer and uncommon EGFR mutations lived almost twice as long without disease ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...

We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Magnus Ofstad. In this article, we will summarize the ...

A long-term study shows no survival advantage for a second transplant in relapsed myeloma, challenging traditional treatment ...

TScan Therapeutics, Inc.’s TCRX share price has surged by 5.15%, which has investors questioning if this is right time to ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Drug ...

Minister of Education and Early Years, Hon. Robin Croucher with the ACT Foundation, teachers, students, community and health partners at the announcement of mandatory CPR, AED, and Opioid Overdose ...